The Big4Bio Company to Watch Program
April 2022: NeuBase Therapeutics

 

THE COMPANY

Drugging the Genome

The spark behind NeuBase’s founding, and how the company is drugging the genome with precision genetic medicine.

 

 

THE TECHNOLOGY

Advancing a New Class of Medicines

Founder and CEO Dietrich Stephan and CFO Todd Branning talk about the company’s precision genetic medicine technology and pipeline.